The US Food and Drug Administration has approved mirdametinib for the treatment of neurofibromatosis type 1 (NF1) in adults ...

Enzyme designers in the David Baker lab at the University of Washington in Seattle, from left: Sam Pellock, Anna Lauko, Kiera ...

Nobel Laureate Prof. Aaron Ciechanover (2004, Chemistry) delivered a special address at the inaugural of ProUPS (Proteostasis ...

By analyzing E. coli protein levels, scientists found a surplus of membrane shuttle proteins that may play a role in ...

New research uses AI to engineer enzymes with intricate active sites, expanding the possibilities for synthetic biocatalysts.

A Cornell University-led collaboration has uncovered the equipment that enables bacteria to survive exposure to antibiotics: a shuttling mechanism that helps a complex of proteins pump out a wide ...

Fresh off winning a Nobel Prize last year, and previously tackling antibodies and peptides, the University of Washington’s ...

Covalent bonding is a widely understood phenomenon that joins the atoms of a molecule by a shared electron pair. But in ...

In a pioneering collaboration with AbbVie, Northwestern researchers have discovered a new way to potentially treat cancer by ...

Latent Labs, the company building AI foundation models to make biology programmable, today emerged from stealth with $50M in total funding to accelerate their progress and partnerships.

Liverpool researchers' discovery of collagen in fossilized bones could provide new insights into dinosaurs. For years, ...